Hearing Loss Trial, Recruiting NCT06919744 Sponsor: University Hospital, Montpellier Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06919744
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been newly diagnosed with a condition called Idiopathic Intracranial Hypertension (IIH) — meaning raised pressure in the skull with no clear cause — within the last 3 months
  • A brain scan (MRI) has shown a narrowing in specific veins that drain blood from your brain (called transverse venous sinuses)
  • Your MRI results are otherwise normal, apart from findings related to IIH
  • You have eye symptoms linked to IIH, including a specific level of swelling of the optic nerve detected during eye examinations (confirm with trial site)
  • Your eye scan (OCT) has NOT shown damage to certain cells at the back of your eye (macular ganglion cells)
  • You are willing and able to attend all scheduled appointments and follow all trial procedures
  • You have signed a consent form after being informed about the trial and data collection
  • You are covered by public health insurance

Who may not be able to join:

  • You have previously been treated with a medication called acetazolamide for IIH
  • You have a known allergy to contrast dye, nickel, or titanium
  • You have taken certain medications (such as lithium, vitamin A, or tetracycline) within 2 months of your diagnosis that can raise pressure in the skull
  • You have a history of blood clots in the brain's veins or a brain tumour
  • You have experienced a rapid and severe loss of vision due to IIH within the past 4 weeks
  • Your eye scan (OCT) shows damage to specific cells at the back of your eye (macular ganglion cells)
  • You have damage (atrophy) to the optic nerve
  • You have a condition called amblyopia (sometimes known as "lazy eye")
  • You have a significant prescription for glasses or contacts, alongside certain other eye conditions such as glaucoma (confirm with trial site)
  • You are pregnant or a pregnancy test has come back positive
  • You have a serious or life-threatening illness that could interfere with the trial or mean you are unlikely to benefit
  • There is evidence of bleeding in or around your brain
  • Your life expectancy is less than 6 months
  • You have chronic (long-term) IIH rather than a new diagnosis
  • You have significant kidney problems (confirm specific levels with trial site)
  • You have previously had a stent placed in a vein inside your skull
  • You have previously had gastric bypass surgery
  • You have a medical reason that prevents you from having a general anaesthetic
  • You cannot take aspirin, clopidogrel, or similar blood-thinning medications
  • You have a history of chronic obstructive pulmonary disease (COPD) or another serious breathing condition
  • You have a history of deep vein thrombosis (DVT) or a blood clot in the lungs (pulmonary embolism)
  • You have a history of atrial fibrillation (an irregular heartbeat) or other conditions that raise your risk of stroke
  • You have certain blood vessel abnormalities in the brain, such as malformations, aneurysms, or significant narrowing of blood vessels (confirm with trial site)
  • The shape or structure of your brain's veins would make the procedure unsafe (confirm with trial site)
  • You are employed by or dependent on the organisation running the trial
  • You have taken part in another clinical trial or received an unapproved medicine within the last 4 weeks
  • You are legally protected under the French Public Health Code, including people under legal guardianship, prisoners, or women who are pregnant, recently given birth, or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 467 339 469

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 September 2025
Est. completion
30 October 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Rate of patients with resolved papilledema and normalization of intra-cranial pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov